januvia pancreatic cancer risk

Future of Type 2 Diabetes Drugs Threatened

According to The New York Times, an animal study requested by Merck for its type 2 diabetes drug, Januvia, revealed worrisome changes in the pancreases of rats, leading to follow-up studies which now threaten the future of the lucrative diabetes drug, as well as all other drugs in its class.

Jury Delivers $40 Million Verdict Holding Johnson & Johnson Accountable for Talc-Related Ovarian Cancer Click Here for More Information.